Lv41
608 积分 2023-11-25 加入
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
3小时前
待确认
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
7个月前
已完结
Microbiota-driven antitumour immunity mediated by dendritic cell migration
11个月前
已完结
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
11个月前
已完结
The next generation of immunotherapies for lung cancers
11个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
1年前
已完结
皖公网安备34019202002308
